Journal of Clinical Lipidology
Volume 3, Issue 2 , Pages 78-84 , April 2009

Postprandial lipemia as an early predictor of cardiovascular complications in childhood obesity

Received 12 November 2008 ,Accepted 8 February 2009.

References 

  1. Lobstein T, Baur L, Uauy R. Obesity in children and young people: a crisis in public health. Obes Rev. 2004;5(suppl 1):4–85
  2. Rosenbloom AL, Joe JR, Young RS, Winter WE. Emerging epidemic of type 2 diabetes in youth. Diabetes Care. 1999;22:345–354
  3. McCrindle BW, Malhoit C. Elevated atherogenic lipoproteins in childhood: risk, prevention, and treatment. J Clin Lipidol. 2008;2:138–146
  4. McMahan CA, Gidding SS, McGill HC. Coronary heart disease risk factors and atherosclerosis in young people. J Clin Lipidol. 2008;2:118–126
  5. Mietus-Synder M, Krauss RM. Lipid metabolism in children and adolescents: impact on vascular biology. J Clin Lipidol. 2008;2:127–137
  6. Higashi K, Ito T, Nakajima K, et al. Remnant-like particle cholesterol is higher in diabetic patients with coronary artery disease. Metabolism. 2001;50:1462–1465
  7. Tomkin GH, Owens D. Abnormalities in apo B-containing lipoproteins in diabetes and atherosclerosis. Diabetes Metab Res Rev. 2001;17:27–43
  8. Schaefer EJ, McNamara JR, Shah PK, et al. Elevated remnant-like particle cholesterol and triglyceride levels in diabetic men and women in the Framingham Offspring Study. Diabetes Care. 2002;23:1766–1769
  9. Proctor SD, Vine DF, Mamo JC. Arterial retention of apolipoprotein B48 and B100-containing lipoproteins in atherogenesis. Curr Opin Lipidol. 2002;13:110–118
  10. Huff MW. Dietary cholesterol, cholesterol absorption, post-prandial lipemia and atherosclerosis. Can J Clin Pharmacol. 2003;10(Suppl A):26A–32A
  11. Twickler T, Dallinga-Thie GM, Chapman MJ, Cohn JS. Remnant lipoproteins and atherosclerosis. Curr Atheroscler Rep. 2005;7:140–147
  12. Mamo JC, Wheeler JR. Chylomicrons or their remnants penetrate rabbit thoracic aorta as efficiently as do smaller macromolecules, including low-density lipoprotein, high-density lipoprotein, and albumin. Coronary Art Dis. 1994;5:695–705
  13. Proctor SD, Pabla CK, Mamo JC. Arterial intimal retention of pro-atherogenic lipoproteins in insulin deficient rabbits and rats. Atherosclerosis. 2000;149:315–322
  14. Coppack SW. Post-prandial lipoproteins in non-insulin-dependent diabetes mellitus. Diabetic Med. 1997;14:S67–S74
  15. Malmström R, Packard CJ, Caslake M, et al. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia. 1997;40:454–462
  16. Duez H, Lamarche B, Uffelman KD, Valero R, Cohn JS, Lewis GF. Hyperinsulinemia is associated with increased production rate of intestinal apolipoprotein B-48-containing lipoproteins in humans. Arterioscler Thromb Vasc Biol. 2006;26:1357–1363
  17. Hogue J, Lamarache B, Tramblay AJ, Bergeron J, Gagné C, Couture P. Evidence of increased secretion of apolipoprotein B48-containing lipoproteins in subjects with type 2 diabetes. J Lipid Res. 2007;48:1336–1342
  18. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Glegal KM. Prevalence of overweight and obesity among US children, adolescents and adults. JAMA. 2004;291:2847–2850
  19. Tjepkema M, Shields M. Measured obesity: overweight Canadian children and adolescents. Nutrition Findings from the Canadian Community Health Survey. Health Report. 2006;17:27–42
  20. Lauer RM, Lee J, Clarke WR. Factors affecting the relationship between childhood and adult cholesterol levels. The Muscatine Study. Pediatrics. 1988;182:309–318
  21. Freedman DS, Khan LK, Dietz WH, Srinivasan SR, Berenson GS. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: The Bogalusa Heart Study. Pediatrics. 2001;108:712–718
  22. Maffeis C, Moghetti P, Grezzani A, Clementi M, Gaudino R, Tatò L. Insulin resistance and the persistence of obesity from childhood into adulthood. J Clin Endocrinol Metab. 2002;87:71–76
  23. Ferraro KF, Thorpe RJ, Wilkinson JA. The life course of severe obesity: does childhood overweight matter?. J Gerontol Series B-Psychol Sci Social Sci. 2003;58:S110–S119
  24. Raitakari OT, Juonala M, Viikari JSA. Obesity in childhood and vascular changes in adulthood: insights into the Cardiovascular Risk in Young Finns Study. Int J Obes. 2005;29:S101–S104
  25. Arslanian S, Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: is “syndrome X” present?. J Clin Endocrinol Metab. 1996;81:1058–1062
  26. Kohen-Avramoglu R, Theriault A, Adeli K. Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia. Clin Biochem. 2003;36:413–420
  27. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care. 2005;28:902–909
  28. Epstein LH, Valoski A, Wing RR, McCurley J. Ten-year outcomes of behavioral family-based treatment for childhood obesity. Health Psychol. 1994;13:373–383
  29. Webber LS, Osganian SK, Feldman HA, et al. Cardiovascular risk factors among children after a 2 ½-year intervention—the CATCH Study. Prev Med. 1996;25:432–441
  30. Robinson TN. Reducing children's television viewing to prevent obesity: a randomized controlled trial. JAMA. 1999;282:1561–1567
  31. Shrewsbury V, Wardle J. Socioeconomic status and adiposity in childhood: a systematic review of cross-sectional studies 1990–2005. Obesity. 2008;16:275–284
  32. Killeen J, Vanderburg D, Harlan WR. Application of weight-height ratios and body indices to juvenile populations: the National Health Examination Survey data. J Chronic Dis. 1978;31:529–537
  33. Frerichs RR, Webber LS, Srinivasan SR, Berenson GS. Relation of serum lipids and lipoproteins to obesity and sexual maturity in white and black children. Am J Epidemiol. 1978;108:486–496
  34. Laskarzewski P, Morrison JA, Mellies MJ, et al. Relationships of measurements of body mass to plasma lipoprotein in school children and adults. Am J Epidemiol. 1980;111:395–406
  35. Resnicow K, Morabia A. The relation between body mass index and plasma total cholesterol in a multiracial sample of US schoolchildren. Am J Lipidemiol. 1990;132:1083–1089
  36. Williams DP, Going SB, Lohman TG, et al. Body fatness and risk for elevated blood pressure, total cholesterol, and serum lipoprotein ratios in children and adolscents. Am J Public Health. 1992;82:358–363
  37. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study. Pediatrics. 1999;103:1175–1182
  38. Reinehr T, Andler W, Denzer C, Siegried W, Hayer H, Wabitsch M. Cardiovascular risk factors in overweight German children and adolescents: relation to gender, age and degree of overweight. Nutr Metab Cardiovasc Dis. 2005;15:181–187
  39. Morrison JA, James FW, Sprecher DL, Khoury PR, Daniels SR. Sex and race differences in cardiovascular disease risk factor changes in schoolchildren, 1975–1990: The Princeton School Study. Am J Public Health. 1999;89:1708–1714
  40. Manios Y, Magkos F, Christakis G, Kafatos AG. Changing relationships of obesity and dyslipidemia in Greek children: 1982–2002. Prev Med. 2005;41:846–851
  41. Burke V, Beilin LJ, Simmer K, et al. Predictors of body mass index and associations with cardiovascular risk factors in Australian children. Int J Obes. 2005;29:15–23
  42. Srinivasan SR, Bao W, Wattingney WA, Berenson GS. Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: The Bogalusa Heart Study. Metabolism. 1996;45:235–240
  43. Nicklas TA, von Duvillard SP, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood: the Bogalusa Heart Study. Int J Sports Med. 2002;23(suppl 1):S39–S43
  44. Srinivasan SR, Frontini MG, Xu J, Berenson GS. Utility of childhood non-high-density lipoprotein cholesterol levels in predicting adult dyslipidemia and other cardiovascular risks: The Bogalusa Heart Study. Pediatrics. 2006;118:201–206
  45. Baker JL, Olsen LW, Sorensen TIA. Childhood body mass index and the risk of coronary heart disease in adulthood. N Engl J Med. 2007;357:2329–2337
  46. DiPietro L, Mossberg H, Stunkard AJ. A 40-year history of overweight children in Stockholm: life-time overweight, morbidity and mortality. Int J Obes. 1994;18:585–590
  47. Falkstedt D, Hemmingsson T, Rasmussen F, Lundbert I. Body mass index in late adolescence and its association with coronary heart disease and stroke in middle age among Swedish men. Int J Obes. 2007;31:777–783
  48. Gunnell DJ, Frankel SJ, Nanchahal K, et al. Childhood obesity and adult cardiovascular mortality: a 57-y follow-up study based on the Boyd Orr cohort. Am J Clin Nutr. 1998;67:1111–1118
  49. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents: a follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992;327:1350–1355
  50. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298:309–316
  51. Børge G, Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298:299–308
  52. Chan DC, Watts GF, Barrett PH, Mamo JC, Redgrave TG. Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity. Clin Chem. 2002;48:278–283
  53. Redgrave TG. Chylomicron metabolism. Biochem Soc Trans. 2004;32:79–82
  54. Duez H, Pavlic M, Lewis GF. Mechanism of intestinal lipoprotein overproduction in insulin resistant humans. Atherosclerosis. 2008;9:33–38
  55. Hsieh J, Hayashi A, Webb J, Adeli K. Post-prandial dyslipidemia in insulin resistance: Mechanisms and role of intestinal insulin sensitivity. Atherosclerosis. 2008;9:7–13
  56. Vine DF, Glimm DR, Proctor SD. Intestinal lipid transport and chylomicron production: possible links to exacerbated atherogenesis in a rodent model of the metabolic syndrome. Athero. Suppl. 2008;9:69–76
  57. Alipour A, Elte JW, van Zaanen HC, Rietveld AP, Cabezas MC. Novel aspects of post-prandial lipemia in relation to atherosclerosis. Athero. Suppl. 2008;9:39–44
  58. Weintraub MS, Grosskopf I, Rassin T, et al. Clearance of chylomicron remnants in normolipidaemic patients with coronary artery disease: case control study over three years. BMJ. 1996;312:936–939
  59. Rajaratnam RA, Gylling H, Miettinen TA. Impaired post-prandial clearance of squalene and apolipoprotein B-48 in post-menopausal women with coronary artery disease. Clin Sci. 1999;97:183–192
  60. Mero N, Malmström R, Steiner G, Taskinen MR, Syvänne M. Post-prandial metabolism of apolipoprotein B-48 and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis. 2000;150:167–177
  61. McNamara JR, Shah PK, Nakajima K, Cupples LA, Wilson PWF, Ordovas JM. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham heart study. Atherosclerosis. 2001;154:229–236
  62. Imke C, Rodriguez BL, Grove JS, et al. Are remnant-like particles independent predictors of coronary heart disease incidence? The Honolulu Heart Study. Arterioscler Thromb Vasc Biol. 2005;25:1718–1722
  63. Smith D, Watts GF, Dane-Stewart C, Mamo JC. Post-prandial chylomicron response may be predicted by a single measurement of plasma apolipoprotein B48 in the fasting state. Eur J Clin. 1999;29:204–209Invest
  64. Dane-Stewart CA, Watts GF, Barrett PH, et al. Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus. Clin Endocrinol. 2003;58:415–420
  65. Chan DC, Watts GF, Barrett PH, et al. Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test. J Lipid Res. 2002;43:706–712
  66. Mamo JC, Watts GF, Barrett PH, Smith D, James AP, Pal S. Post-prandial dyslipidemia in men with visceral obesity: an effect of reduced LDL receptor expression?. Am J Physiol Endocrinol Metab. 2001;281:E626–E632
  67. Redgrave TG, Watts GF, Martins IJ, Barrett PHR, Mamo JCL, Dimmitt SB, et al. Chylomicron remnant metabolism in familial dyslipidemias studied with a remnant-like emulsion breath test. J Lipid Res. 2001;42:710–715
  68. Nzekwu MMU, Ball GDC, Jetha MM, Beaulieu C, Proctor SD. Apolipoprotein B48: a novel marker of metabolic risk in overweight children?. Biochem Soc Trans. 2007;25:484–486
  69. Humphries MC, Gutin B, Barbeau P, Vemulapalli S, Allison J, Owens S. Relations of adiposity and effects of training on the left ventricle in obese youths. Med Sci Sports Exercise. 2002;34:1428–1435

PII: S1933-2874(09)00081-6

doi: 10.1016/j.jacl.2009.02.006

Journal of Clinical Lipidology
Volume 3, Issue 2 , Pages 78-84 , April 2009

Article Tools